US Imaging for the Assessment of LUTS
Part of paid clinical trials in Madison, Wisconsin.
- Sponsor
- University of Wisconsin, Madison
- Study ID
- NCT06323109
- Status
- Recruiting
Conditions
- BPH
- Lower Urinary Tract Symptoms
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Accepted
Interventions
- MRI-UDS; US-UDS; MCUD — DEVICEImaging procedures will include a comprehensive protocol of dynamic MRI, 3D ultrasound and MCUD to evaluate and validate this entirely novel methodology.
Study Details
The purpose of this research is to develop an ultrasound (US) based urodynamics (UDS) evaluation of voiding based on successful magnetic resonance imaging (MRI)-UDS evaluation. Both US and MRI are non-invasive imaging techniques, but US is a more cost-effective and widely available technology. 80 participants will be enrolled and will be on study for up to 2.5 hours (1.5 hour MRI and 1 hour US).
Key Dates
- Start date
- Nov 28, 2023
- Status verified
- Dec 2025
- Primary completion
- Jan 31, 2027
- Completion
- Jan 31, 2027
Study Design
- Enrollment
- 80 participants (estimated)
Arms
- Arm: Healthy ControlsAge-matched healthy men with no lower urinary tract symptoms
- Arm: Known BPH/LUTSAdult men diagnosed with BPH/LUTS
Primary Outcome Measure
MRI Urodynamics - Change in Bladder Volume [ Time Frame: Research visit 1 day ]
Central Contacts
- Radiology Studies608-282-8349
- Suzanne Hanson, BS608.262.7269
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Wisconsin | Madison | Wisconsin | 53705 | Alejandro Roldan-Alzate, PhD (PRINCIPAL_INVESTIGATOR) Wade Bushman, MD, PhD (SUB_INVESTIGATOR) Matt Grimes, MD (SUB_INVESTIGATOR) Giuseppe Toia, MD (SUB_INVESTIGATOR) Ivan Rosado-Mendez, PhD (SUB_INVESTIGATOR) |
Find similar trials in Madison, WI
By research site
Related Studies
- HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate CancerRecruiting · University of Kansas Medical Center · Kansas City, Kansas
- 5-Alpha Reductase 2 as a Marker of Resistance to 5ARI TherapyRecruiting · Beth Israel Deaconess Medical Center · Boston, Massachusetts
- BPH Global RegistryRecruiting · Société Internationale d'Urologie · Los Angeles, California
- Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEPPHASE3 · Recruiting · Northwestern University · Chicago, Illinois